PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY
C. Kosmas et al., PACLITAXEL (TAXOL)-IFOSFAMIDE-CISPLATIN (TIP) CHEMOTHERAPY (CMT) REGIMEN IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 449-449